CCCC - C4 Therapeutics, Inc.
IEX Last Trade
3.76
-0.090 -2.394%
Share volume: 20,524
Last Updated: Fri 27 Dec 2024 05:30:33 PM CET
Research and Development in Biotechnology (except Nanobiotechnology):
-0.39%
PREVIOUS CLOSE
CHG
CHG%
$3.85
-0.09
-2.34%
View ratios
| Fiscal Date | 2022-09-30 | 2022-12-31 | 2023-03-31 | 2023-06-30 | 2023-09-30 | 2023-12-31 | 2024-03-31 | 2024-06-30 | |
|---|---|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q3 2022 | Q4 2022 | Q1 2023 | Q2 2023 | Q3 2023 | Q4 2023 | Q1 2024 | Q2 2024 | |
| Report Date | 2022-11-03 | 2023-02-23 | 2023-05-04 | 2023-08-08 | 2023-11-01 | 2024-02-22 | 2024-05-08 | 2024-08-01 | |
| Total revenue | 6.754 M | 2.854 M | 3.759 M | 2.664 M | 11.072 M | 3.261 M | 3.039 M | 12.006 M | |
| Cost of revenue | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Gross profit | 6.754 M | 2.854 M | 3.759 M | 2.664 M | 11.072 M | 3.261 M | 3.039 M | 12.006 M | |
| -57.74% | 31.71% | -29.13% | 315.62% | -70.55% | -6.81% | 295.06% | |||
| Operating expenses | 39.242 M | 41.147 M | 39.987 M | 40.232 M | 38.880 M | 40.688 M | 32.821 M | 33.448 M | |
| Selling general and admin | 9.579 M | 10.495 M | 10.945 M | 10.306 M | 10.533 M | 10.297 M | 10.288 M | 9.695 M | |
| Research and development | 29.663 M | 30.652 M | 29.042 M | 29.926 M | 28.347 M | 30.391 M | 22.533 M | 23.753 M | |
| Total expenses | 39.242 M | 41.147 M | 39.987 M | 40.232 M | 38.880 M | 40.688 M | 32.821 M | 33.448 M | |
| 4.85% | -2.82% | 0.61% | -3.36% | 4.65% | -19.33% | 1.91% | |||
| Operating income | -32.488 M | -38.293 M | -36.228 M | -37.568 M | -27.808 M | -37.427 M | -29.782 M | -21.442 M | |
| Ebit | -32.488 M | -38.293 M | -36.228 M | -37.568 M | -27.808 M | -37.427 M | -29.782 M | -21.442 M | |
| Pretax income | -31.958 M | -37.185 M | -34.780 M | -35.922 M | -26.034 M | -34.477 M | -28.361 M | -17.716 M | |
| 16.36% | -6.47% | 3.28% | -27.53% | 32.43% | -17.74% | -37.53% | |||
| Income tax | 0.000 | 0.000 | 0.000 | 0.000 | 1.003 M | 277.000 K | 0.000 | 0.000 | |
| Net income basic | -31.958 M | -37.185 M | -34.780 M | -35.922 M | -27.037 M | -34.754 M | -28.361 M | -17.716 M | |
| -16.36% | 6.47% | -3.28% | 24.73% | -28.54% | 18.40% | 37.53% | |||
| Net income | -31.958 M | -37.185 M | -34.780 M | -35.922 M | -27.037 M | -34.754 M | -28.361 M | -17.716 M | |
| -16.36% | 6.47% | -3.28% | 24.73% | -28.54% | 18.40% | 37.53% |